Concepedia

Wojciech Szymanowski

WS

Statistics

Publications

5

Citations

60

H-Index

5

Active since

2017

Affiliations

Medical University of Białystok(Current)

Wojciech Szymanowski is an author at Medical University of Białystok specializing in oncology, pharmacology, and apoptosis.

Publications per year

2017–2023

5

Publications

5

Synthesis, Biological Activity, ADME and Molecular Docking Studies of Novel Ursolic Acid Derivatives as Potent Anticancer Agents

Olga Michalak, Marcin Cybulski, Wojciech Szymanowski et al. · International Journal of Molecular Sciences · 2023 · 15 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +14

Multi-Targeting Anticancer Activity of a New 4-Thiazolidinone Derivative with Anti-HER2 Antibodies in Human AGS Gastric Cancer Cells

Agnieszka Gornowicz, Roman Lesyk, Robert Czarnomysy et al. · International Journal of Molecular Sciences · 2023 · 13 citations · Full text

Medicine, Oncology, Pharmacology +17

Mechanism of anticancer action of novel berenil complex of platinum(II) combined with anti-MUC1 in MCF-7 breast cancer cells

Agnieszka Gornowicz, Anna Bielawska, Wojciech Szymanowski et al. · Oncology Letters · 2017 · 11 citations · Full text

Medicine, Oncology, Pharmacology +16

Anticancer Effect of a Novel Octahydropyrazino[2,1-a:5,4-a′]diisoquinoline Derivative and Its Synergistic Action with<i> Nigella sativa</i> in Human Gastric Cancer Cells

Anna Czajkowska, Agnieszka Gornowicz, Natalia Pawłowska et al. · BioMed Research International · 2017 · 11 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +14

Anti-HER2 monoclonal antibodies intensify the susceptibility of human gastric cancer cells to etoposide by promoting apoptosis, but not autophagy

Agnieszka Gornowicz, Wojciech Szymanowski, Robert Czarnomysy et al. · PLoS ONE · 2021 · 10 citations · Full text

Life Sciences, Oncology, Pharmacology +17

1–5 of 5